Andrea P Espejo-Freire

7PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 10, 2025
5-fluoro-deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long-term outcomes in soft tissue sarcomas: Results from a prospective trial.

Edward Y Cheng, Andrea P Espejo Freire, Juan C Manivel

|Jun 26, 2025
DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas.

Kurt Statz-Geary, Andrew Elliott, Steven Bialick

|Mar 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma.

Galina Lagos, Roman Groisberg, Andrew Elliott

|Jan 25, 2025
Clinical Benefit of Pegylated Liposomal Doxorubicin and High Prevalence of Pre-Existing Psychiatric Conditions in Patients with Desmoid-Type Fibromatosis.

Andrea Espejo Freire, Keith M Skubitz

|Nov 15, 2024
Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors.

Philippos Apolinario Costa, Arshia Arora, Yannelys Fernandez

|Feb 02, 2022
Treatment of Disseminated Intravenous Leiomyomatosis With ALK Targeting Crizotinib: A Successful Case Report.

Priscila Barreto-Coelho, Andrew Rosenberg, Ty Subhawong

Pageof 2

Frequent Collaborators

4 joint publications

Jonathan C Trent

3 joint publications

Philippos Costa

2 joint publications

Matthew Oberley

2 joint publications

Gina Z D'Amato